ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

The Cancer Letter Wins Journalism Award

April 1, 2011

In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress

June 16, 1978

Straus asks to “Set Record Straight”

September 2, 1988

MD Anderson Completes $500 Million Research Endowment

September 24, 2010